CCL2 and metabolic dysfunction-associated steatohepatitis: In an experimental NASH animal model, S1PR1 knockdown inhibited saturated fat-induced NF-κB signaling and decreased the mRNA expression level of TNFα and monocyte chemoattractant protein 1 (MCP1) in HepG2 cells (74).